SEC Form D · filed July 7, 2022
Adamis Pharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Richard C. Williams · San Diego, CADirectorHoward C. Birndorf · San Diego, CADirectorRonald B. Moss · San Diego, CAExecDavid J. Marguglio · San Diego, CAExec · DirectorCarl Gordon · San Diego, CAExec · DirectorCharles B. Chippero · ROSWELL, GADirectorYi Liu · San Diego, CADirectorAlan B. Laing · PHOENIX, AZExecVickie S. Reed · San Diego, CADirectorMeera J. Desai · San Diego, CADirectorDavid C. Benedicto · San Diego, CAExecAdam E. Graev · New York, NYExecDerek P. Hodges · Huntingtown, MDDirectorJoseph P. Simpson · Owings, MDDirectorHam K. Serunjogi · San Francisco, CAExec · DirectorVickie S. Reed · San Diego, CADirectorMeera J. Desai · San Diego, CADirectorDavid C. Benedicto · San Diego, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗